We report here two crystal structures of a recombinant single-chain Fv fragment of mAb 1696,expressed in E. coli, as a complex with a cross-reactive peptides from the HIV-1 PR and theHIV-2 PR at 2.7 ? resolution and 1.9 ? resolution respectively. On the basis of the interactionsseen in the complex three-dimensional structures, the cross-reactivity between mAb 1696 withthe HIV-1 and HIV-2 protease and their N-terminal peptides can be explained. In addition, acandidate mechanism of HIV PR inhibition by mAb 1696 is proposed which may help thedesign of alternative HIV protease inhibitors, aimed at dissociating the homodimeric viral enzyme."> We report here two crystal structures of a recombinant single-chain Fv fragment of mAb 1696,expressed in E. coli, as a complex with a cross-reactive peptides from the HIV-1 PR and theHIV-2 PR at 2.7 ? resolution and 1.9 ? resolution respectively. On the basis of the interactionsseen in the complex three-dimensional structures, the cross-reactivity between mAb 1696 withthe HIV-1 and HIV-2 protease and their N-terminal peptides can be explained. In addition, acandidate mechanism of HIV PR inhibition by mAb 1696 is proposed which may help thedesign of alternative HIV protease inhibitors, aimed at dissociating the homodimeric viral enzyme."> We report here two crystal structures of a recombinant single-chain Fv fragment of mAb 1696,expressed in E. coli, as a complex with a cross-reactive peptides from the HIV-1 PR and theHIV-2 PR at 2.7 ? resolution and 1.9 ? resolution respectively. On the basis of the interactionsseen in the complex three-dimensional structures, the cross-reactivity between mAb 1696 withthe HIV-1 and HIV-2 protease and their N-terminal peptides can be explained. In addition, acandidate mechanism of HIV PR inhibition by mAb 1696 is proposed which may help thedesign of alternative HIV protease inhibitors, aimed at dissociating the homodimeric viral enzyme."> Structural basis of HIV-1 and HIV-2 protease inhibition bya monoclona…
Number of the records: 1  

Structural basis of HIV-1 and HIV-2 protease inhibition bya monoclonal antibody

  1. SYS0191543
    LBL
    		00000nam^^22^^^^^^^^450
    005
    		20200403121058.4
    101
    0-
    		$a eng
    102
    		$a CZ
    200
    1-
    		$a Structural basis of HIV-1 and HIV-2 protease inhibition bya monoclonal antibody
    215
    		$a 2 s.
    463
    -1
    		$1 011 $a 1211-5894 $1 200 1 $a Material Structure in Chemistry, Biology, Physics and Technology $v s. 70 $1 210 $a Praha, Česká republika $c Czech and Slovak Crystallographic Association $d 2003 $1 702 1 $a Kužel $b R. $4 340 $1 702 1 $a Hašek $b J. $4 340 $1 702 1 $a Fiala $b J. $4 340 $1 702 1 $a Wiss $b Z. $4 340
    610
    1-
    		$a antibody fragment
    610
    1-
    		$a crystal structure
    610
    1-
    		$a HIV protease inhibition
    700
    -1
    		$3 cav_un_auth*0105483 $a Řezáčová $b Pavlína $p UMG-J $w Laboratory of Structural Biology $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i.
    701
    -1
    		$3 cav_un_auth*0015955 $a Lescar $b J. $y FR $4 070
    701
    -1
    		$3 cav_un_auth*0105330 $a Brynda $b Jiří $p UMG-J $w Laboratory of Structural Biology $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i.
    701
    -1
    		$3 cav_un_auth*0105360 $a Fábry $b Milan $p UMG-J $w Laboratory of Structural Biology $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i.
    701
    -1
    		$3 cav_un_auth*0022382 $a Bentley $b G. A. $y FR $4 070
    701
    -1
    		$3 cav_un_auth*0105486 $a Sedláček $b Juraj $p UMG-J $w Laboratory of Structural Biology $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i.

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all